0
Abstract: Poster Presentations |

PUENTES DE ESPERANZA: A BINATIONAL ALLIANCE FOR THE TREATMENT OF MULTI-DRUG RESISTANT TB IN THE CALIFORNIAS FREE TO VIEW

Rafael Laniado-Laborin, MD, MPH*; Kathleen Moser, MD, MPH; Sundari Mase, MD; Julia Estrada-Guzman, MD; Jose Luis Burgos-Regil, MD; Maria Guadalupe Felix-Herrera, MD
Author and Funding Information

Hospital General de Tijuana, Tijuana, Mexico


Chest


Chest. 2007;132(4_MeetingAbstracts):642. doi:10.1378/chest.132.4_MeetingAbstracts.642
Text Size: A A A
Published online

Abstract

PURPOSE: In 2006 the state of Baja California had the highest TB rate in Mexico(47.8 per 100,000). Three different surveys have reported a rate of multidrug resistant tuberculosis (MDR-TB) between 6 and 17%. Puentes de Esperanza was created as a binational USA-Mexico program to diagnose, treat and prevent MDR-TB. The program will also enhance activities already underway in Baja California including laboratory diagnosis,training of outreach workers to support patient adherence and education of community professionals at all practice levels.

METHODS: The program funded by USAID has created a binational alliance of government and nongovernment providers and organizations (including the Mexican National TB Program). It receives referrals of MDR-TB cases from Baja California's medical community; all cases are confirmed by culture and susceptibility testing. Partners confer and monitor patient clinical progress and outcomes regularly through the use of inexpensive telecomunication technology, and in-person case conferences. Individualized regimens with second line drugs are provided under strict directly observed therapy.

RESULTS: Five patients have already started treatment; three with a strain resistant to five antituberculosis drugs and two with a strain resistant to six drugs; three teleconferences have been implemented to discuss these complex MDR-TB cases with program managers and providers from Mexico and the United States.

CONCLUSION: The program has created the infrastructure needed to support early recognition of affected patients and generated outreach services to assist patients with successful adherence to treatment, creating a sustainable binational network of MDR-TB professionals.

CLINICAL IMPLICATIONS: Unable to get curative treatment, MDR patients in Baja California become increasing ill over a period of years during which they are able to spread the disease within the US-Mexico border communities. We expect that in our first year, 10-20 MDR-TB patients will receive treatment. However, the impact will be broader since transmission of this airborne disease will be curtailed. Therefore, treatment of 20 patients can prevent more than 200 new infections with MDR-TB and partnering with local providers will help reduce future misuse of antituberculosis drugs.

DISCLOSURE: Rafael Laniado-Laborin, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 24, 2007

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543